Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Diabetologia 54 , S38 (2011)
Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial
Target-based drug discovery: is something wrong
Rather, they illustrate clinical contexts in which substrate-sensitive proportionality may be more vulnerable during sustained hypophagia
US$ 20.02
US$ 25.14
US$ 28.01
US$ 21.98
US$ 23.58
